相关实验视频
Updated: Jun 26, 2025

10:15
Isolation and Culture Expansion of Tumor-specific Endothelial Cells
Published on: October 14, 2015
11.2K
在固体瘤的微环境中,瘤内皮细胞和免疫细胞之间的信号交叉
Yuexin Xu1, Chris P Miller1, Scott S Tykodi2,3
1Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Frontiers in cell and developmental biology
|May 10, 2024
概括
与瘤相关的内皮细胞 (TECs) 产生异常的瘤血管,阻碍抗癌免疫力并促进转移. 准TEC和免疫细胞交叉通话是有效的癌症治疗的关键.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 血管生物学 血管生物学
背景情况:
- 与瘤相关的内皮细胞 (TEC) 是瘤微环境 (TME) 的关键调节者.
- 通过异常的血管形成,TECs协调免疫监测和免疫逃逸.
- TECs促进瘤细胞转移,并影响免疫细胞透和功能.
研究的目的:
- 审查TEC和瘤透免疫细胞之间的复杂信号交叉.
- 突出了针对这种相互作用的治疗策略的见解.
- 讨论结合疗法的潜力,包括血管正常化和增强抗瘤免疫力.
主要方法:
- 关于TEC和免疫细胞相互作用的当前研究的文献综述.
- 分析涉及TEC功能和免疫调节的信号通路.
- 综合关于治疗向策略的信息.
主要成果:
- 由血管性因素驱动的TECs在TME内建立了免疫抑制环境.
- 异常的瘤血管系统选择性地招募免疫抑制细胞并阻断抗瘤免疫细胞.
- 瘤透免疫细胞可以诱导TEC无能,进一步影响TME.
- TEC和免疫细胞参与相互信号传递,影响癌症的进展和转移.
结论:
- 了解TEC和免疫细胞之间的复杂交叉对癌症治疗至关重要.
- 准TEC及其与免疫细胞的相互作用提供了有前途的治疗途径.
- 旨在血管正常化和增强抗瘤免疫力的联合治疗方法对于改善患者的治疗结果至关重要.
相关概念视频
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Regulation of Angiogenesis and Blood Supply
2.6K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.6K
Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K
Interactions Between Signaling Pathways
6.3K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.3K
Tumor Immunotherapy
518
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
518
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K

